| Autor: |
Luszczak S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Simpson BS; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Sathyadevan VK; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Echeverria LMC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Kumar C; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Costa H; 2Research Department of Pathology, University College London, London, UK., Haider A; 2Research Department of Pathology, University College London, London, UK., Freeman A; 2Research Department of Pathology, University College London, London, UK., Jameson C; 2Research Department of Pathology, University College London, London, UK., Ratynska M; 2Research Department of Pathology, University College London, London, UK., Ben-Salha I; 2Research Department of Pathology, University College London, London, UK., Sridhar A; Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK., Shaw G; Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK., Kelly JD; Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK., Pye H; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Gately KA; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland., Whitaker HC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk. |
